Article 1 to 1 out of 1 concerning Samaritan Pharmaceuticals, Inc.
Quest PharmaTech announces sale of non-core assets(08/11/2006) Quest disengages completely from China Quest PharmaTech Inc. has signed an agreement with Shanghai Gaojing Capital Management Co. Ltd., to sell its manufacturing plant in China (Shanghai Hua Gao Pellet Core Pharmaceutical Ltd. or SHGP) for gross proceeds of 1,250,000 RMB (about ...
Top